About Emerge Diagnostics
Emerge Diagnostics is a private company based in Carlsbad, California. It has reported $7,047,350 raised in nine offerings on Form D since July 2014. Its chief executive is David Saunders.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 18, 2023 | Nov 2, 2023 | $105,000target not set | 3 | $35,000 | Equity, Debt, OptionsRule 506(b) | Form D ↗ |
| Nov 9, 2021 | Nov 16, 2021 | $150,000of $500K target | 1 | $150K | Equity, Debt, OptionsRule 506(b) | Form D ↗ |
| Feb 25, 2021 | Mar 3, 2021 | $200,396of $500K target | 2 | $100K | Equity, OptionsRule 506(b) | Form D ↗ |
| Sep 28, 2020 | Oct 1, 2020 | $550,000fully sold | 1 | $550K | EquityRule 506(b) | Form D ↗ |
| Dec 23, 2019 | Dec 31, 2019 | $267,000of $500K target | 1 | $267K | EquityRule 506(b) | Form D ↗ |
| Jun 12, 2017 | Jun 28, 2017 | $250,000of $8.0M target | 1 | $250K | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 10, 2016 | Jun 23, 2016 | $1,850,000of $2.3M target | 5 | $370K | EquityRule 506(b) | Form D ↗ |
| Nov 24, 2014 | Dec 10, 2014 | $2,789,954of $3.0M target | 1 | $2.7M | EquityRule 506(b) | Form D ↗ |
| Jul 3, 2014 | Jul 7, 2014amended Dec 10, 2014 | $885,000of $900K target | 5 | $177K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, nine offerings | $7,047,350 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Emerge Diagnostics's Form D filed Nov 2, 2023.
MS
Mark Sampson
Director
First appears on the Form D that Emerge Diagnostics filed on June 23, 2016; on 7 of its 12 filings.
Mark Sampson appears on 8 Form D filings at 2 companies:
- Escreen, director: Jan 14, 2010
- Emerge Diagnostics, director: Jun 23, 2016 · Jun 28, 2017 · Dec 31, 2019 · Oct 1, 2020 · Mar 3, 2021 · Nov 16, 2021 · Nov 2, 2023
TW
Thomas Webster
Director
First appears on the Form D that Emerge Diagnostics filed on December 31, 2019; on 5 of its 12 filings.
Thomas Webster appears on 12 Form D filings at 2 companies:
- Sandel Avionics, director: Sep 6, 2018 · Jan 4, 2019 · Mar 25, 2019 (amended) · Oct 24, 2019 · Nov 20, 2019 (amended) · Jan 3, 2020 (amended) · Apr 2, 2020 (amended)
- Emerge Diagnostics, director: Dec 31, 2019 · Oct 1, 2020 · Mar 3, 2021 · Nov 16, 2021 · Nov 2, 2023
ML
Murray Lappe
Director
First appears on the Form D that Emerge Diagnostics filed on June 23, 2016; on 7 of its 12 filings.
Murray Lappe appears on 11 Form D filings at 3 companies:
- Escreen, director: Jan 14, 2010
- Emerge Diagnostics, director: Jun 23, 2016 · Jun 28, 2017 · Dec 31, 2019 · Oct 1, 2020 · Mar 3, 2021 · Nov 16, 2021 · Nov 2, 2023
- Sandel Avionics, director: Nov 20, 2019 (amended) · Jan 3, 2020 (amended) · Apr 2, 2020 (amended)
GW
Greer Woodruff
Director
First appears on the Form D that Emerge Diagnostics filed on December 31, 2019; on 5 of its 12 filings.
RT
Robert Thompson
Director
First appears on the Form D that Emerge Diagnostics filed on July 7, 2014; on 10 of its 12 filings.
Robert Thompson appears on 20 Form D filings at 3 companies. Show all
- Escreen, president and CEO, director: Jan 14, 2010
- Emerge Diagnostics, director: Jul 7, 2014 · Dec 10, 2014 (2 filings) · Jun 23, 2016 · Jun 28, 2017 · Dec 31, 2019 · Oct 1, 2020 · Mar 3, 2021 · Nov 16, 2021 · Nov 2, 2023
- Sandel Avionics, executive officer and director: Nov 23, 2016 (amended) · Mar 31, 2017 · Sep 6, 2018 · Jan 4, 2019 · Mar 25, 2019 (amended) · Oct 24, 2019 · Nov 20, 2019 (amended) · Jan 3, 2020 (amended) · Apr 2, 2020 (amended)
DS
David Saunders
President and CEO
First appears on the Form D that Emerge Diagnostics filed on November 2, 2023; on 1 of its 12 filings.
MC
Michael Connor
Director
First appears on the Form D that Emerge Diagnostics filed on June 23, 2016; on 7 of its 12 filings.
Earlier filings also listed
- David Riker · president and CEO, directorLast listed on the Form D that Emerge Diagnostics filed on November 16, 2021; on 1 of its 12 filings.
- Phil Reaston · executive officerLast listed on the Form D that Emerge Diagnostics filed on March 3, 2021; on 8 of its 12 filings.
- MaryRose Cusimano-Reaston, Ph.D. · president and CEOLast listed on the Form D that Emerge Diagnostics filed on March 3, 2021; on 2 of its 12 filings.
- MaryRose Cusimano-Reaston · chief executive officerLast listed on the Form D that Emerge Diagnostics filed on December 31, 2019; on 1 of its 12 filings.
- William Quirk · directorLast listed on the Form D that Emerge Diagnostics filed on June 28, 2017; on 2 of its 12 filings.
- Scott Wolesson · directorLast listed on the Form D that Emerge Diagnostics filed on June 28, 2017; on 2 of its 12 filings.
- Mary Rose Reaston · executive officerLast listed on the Form D that Emerge Diagnostics filed on June 28, 2017; on 5 of its 12 filings.
- Jerry Wilkins · executive officer and directorLast listed on the Form D that Emerge Diagnostics filed on June 28, 2017; on 7 of its 12 filings.